|
🐜
|
Protein C Deficiency: A Database of Mutations, 1995 Update
14 auth.
P. Reitsma,
F. Bernardi,
R. Doig,
S. Gandrille,
J. Greengard,
H. Ireland,
M. Krawczak,
B. Lind,
G. Long,
S. Poort,
...
H. Saito,
N. Sala,
I. Witt,
D. Cooper
|
8 |
1995 |
8
🐜
|
|
🐜
|
Protein S Deficiency: A Database of Mutations – Summary of the First Update
16 auth.
S. Gandrille,
Delphine Borgel,
N. Sala,
Y. Espinosa-Parrilla,
R. Simmonds,
S. Rezende,
B. Lind,
C. Mannhalter,
Ingrid Pabinger,
P. Reitsma,
...
C. Formstone,
D. Cooper,
H. Saito,
Koji Suzuki,
F. Bernardi,
Martine Aiach
|
7 |
2000 |
7
🐜
|
|
🐜
|
Very low cadmium concentrations stimulate DNA synthesis and cell growth.
7 auth.
T. Zglinicki,
C. Edwall,
E. Ostlund,
B. Lind,
M. Nordberg,
Nils R. Ringertz,
...
J. Wróblewski
|
6 |
1992 |
6
🐜
|
|
🐜
|
The role of fragment X polymers in the fibrin enhancement of tissue plasminogen activator-catalyzed plasmin formation.
7 auth.
E. Suenson,
P. Bjerrum,
Arne Holm,
B. Lind,
Morten Meldal,
J. Selmer,
...
L. Petersen
|
5 |
1990 |
5
🐜
|
|
🐬
|
Mutations at the C-terminal isoleucine and other potential iron ligands of 5-lipoxygenase.
T. Hammarberg,
Y. Y. Zhang,
B. Lind,
O. Rådmark,
B. Samuelsson
|
5 |
1995 |
5
🐬
|
|
🐬
|
Iron content of human 5-lipoxygenase, effects of mutations regarding conserved histidine residues.
Y. Y. Zhang,
B. Lind,
O. Rådmark,
B. Samuelsson
|
5 |
1993 |
5
🐬
|
|
🦁
|
A novel missense mutation in the human plasmin inhibitor (alpha2‐antiplasmin) gene associated with a bleeding tendency
B. Lind,
S. Thorsen
|
5 |
1999 |
5
🦁
|
|
🐬
|
A Specific Immunologic Assay for Functional Plasminogen Activator Inhibitor 1 in Plasma – Standardized Measurements of the Inhibitor and Related Parameters in Patients with Venous Thromboembolic Disease
M. Philips,
A. Juul,
J. Selmer,
B. Lind,
S. Thorsen
|
4 |
1992 |
4
🐬
|
|
🐬
|
Saccharomyces cerevisiae leukotriene A4 hydrolase: formation of leukotriene B4 and identification of catalytic residues.
F. Kull,
E. Ohlson,
B. Lind,
J. Haeggström
|
4 |
2001 |
4
🐬
|
